Literature DB >> 11459321

High risk human papillomavirus in oral squamous carcinoma: evidence of risk factors in a Venezuelan rural population. Preliminary report.

G Premoli-De-Percoco1, J L Ramirez.   

Abstract

In a search for the presence of human papillomavirus (HPV) and some etiologic cofactors in oral squamous cell carcinoma (OSCC), 50 women diagnosed as OSCC were analyzed by a multiplex polymerase chain reaction (PCR) assay specific for HPV types 6, 11, 16, and 18. This study revealed that 60% (30/50) of the OSCC patients were positive for HPV-DNA sequences. This group was analyzed according to smoking, alcohol consumption, number of pregnancies, poor oral health and low social economic status. The current results indicate an increased incidence of HPV malignant types in the oral cavity in women with OSCC. Also, they support a multifactorial model of oral cancer causation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459321     DOI: 10.1034/j.1600-0714.2001.300605.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  3 in total

Review 1.  Evidences suggesting involvement of viruses in oral squamous cell carcinoma.

Authors:  Kanupriya Gupta; Rashmi Metgud
Journal:  Patholog Res Int       Date:  2013-12-19

2.  Detection of human papilloma virus-E6/E7 proteins of high-risk human papilloma virus in saliva and lesional tissue of oral squamous cell carcinoma patients using nested multiplex polymerase chain reaction: A comparative study.

Authors:  Rajbir Kaur Grewal; Keya Sircar; Kishore G Bhat; Dilpreet Singh Grewal; Krishan Kumar Tyagi; Simon David
Journal:  J Oral Maxillofac Pathol       Date:  2018 Sep-Dec

3.  Human papillomavirus prevalence in oral and oropharyngeal squamous cell carcinoma in South America: A systematic review and meta-analysis.

Authors:  Antônio Carlos Oliveira; Israel Carlos Cavalcanti de Lima; Vitor Marcelo Frez Marques; Wudson Henrique Alves de Araújo; Chrystiano de Campos Ferreira
Journal:  Oncol Rev       Date:  2022-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.